Prague

• Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combination for Inflammatory Bowel Disease Pending
  2025-524640-35-00 4 Ulcerative colitis (Inflammatory Bowel Disease)
• Prevention of radiation-induced salivary gland damage by botulinum toxin application in patients with head and neck cancers Pending
  2025-524720-22-00 4 patients with head and neck squamous cell carcinoma (HNSCC)
• Study to assess the relative bioavailability of Neludolat versus YAZ in healthy female subjects. Pending
  2025-524871-22-00 2 Healthy subjects
• A Phase II study to investigate lung function with 2 different doses of inhaled glycopyrronium taken with BFF compared to BFF in participant … Pending
  2025-524914-26-00 4 Asthma
• A study comparing different dosage forms of midazolam and how they are taken up in the body. Pending
  2025-524999-37-00 3 Bioavailability Study under Fasting Conditions
• A Randomized Phase III Study to Investigate the Efficacy and Safety of Alpha1H as a Neoadjuvant Therapy in Participants with Low- to Interme … Pending
  2026-525531-16-00 5 Non-Muscle Invasive Papillary Bladder Cancer
• Efficacy and safety of pharmacological therapy of obesity in liver transplant candidates Pending
  2026-526044-12-00 6 Obesity
• Bioequivalence Study of Dapagliflozin 10 mg Pending
  2026-526840-10-00 2 Not applicable (submitted trial is a BE study in healthy participants)
• A study of LY4268989 in participants with Moderately to Severely Active Ulcerative Colitis (EMERALD-3) Recruiting
  2025-524404-29-00 4 2026-06-24 Ulcerative Colitis, Active Moderate
• DAREON®-Lung-1: A study in people with advanced small cell lung cancer to compare obrixtamig plus atezolizumab, carboplatin, and etoposide t … Recruiting
  2025-520565-51-00 5 2026-06-23 small cell lung cancer
• A maintenance study to investigate the efficacy and safety of duvakitug in participants with moderately to severely active ulcerative coliti … Recruiting
  2025-521038-27-00 5 2026-06-23 Immune system diseases
• Revumenib Treatment in Combination with FLA Chemotherapy in Paediatric Refractory/Relapsed KMT2A-r, NUP98-r or NPM1-mut Acute Myeloid Leukem … Recruiting
  2025-521390-14-00 4 2026-06-22 Acute Myeloid Leukemia
• A clinical trial of EYE201/MK-8748 in people with macular degeneration (MK-8748-003) Recruiting
  2025-524894-17-00 10 2026-06-22 Neovascular age-related macular degeneration (NVAMD)
• Phase I/II combination umbrella trial in progressive/relapsed/refractory pediatric low-grade glioma (pLGG) (EPILOGUE) Recruiting
  2024-516896-34-00 9 2026-06-17 progressive/relapsed/refractory pediatric low-grade glioma (pLGG)
• An efficacy and safety study of cenegermin ophthalmic solution compared with vehicle in the treatment of PCED Recruiting
  2025-523443-35-00 5 2026-06-11 Persistent Corneal Epithelial Defect (PCED)
• Open-label Extension of KarXT + KarX-EC for Agitation in Alzheimer’s Disease Recruiting
  2024-519994-20-00 5 2026-06-01 Agitation Associated with Alzheimer’s Disease
• Crohn’s Head-to-Head Assessing Risankizumab Versus Guselkumab for One Year Recruiting
  2025-521590-13-00 5 2026-05-28 Moderately to Severely Active Crohn’s Disease
• An Efficacy and Safety Study of Clemizole HCl in Patients with Lennox-Gastaut Syndrome Recruiting
  2025-522552-20-00 5 2026-05-28 Lennox-Gastaut Syndrome
• Pregabalin or Baclofen in Spastic Motor Behavior Treatment After SCI (PoBSCI), Prospective, Double-Blind, Randomised Drug Study Recruiting
  2024-518824-56-00 5 2026-05-26 Complete to incomplete (AIS A-C) sub-acute cervical or thoracic (NLI C
• A Long-Term Extension Study of IMVT-1402 in Adult Patients With Graves' Disease Recruiting
  2025-524001-33-00 4 2026-05-22 Graves’ Disease
• Evaluation of the efficacy and safety of Magnetic Resonance Angiography (MRA) using gadopiclenol compared to gadoterate meglumine in the ass … Recruiting
  2024-518835-13-00 5 2026-05-19 Suspected Vascular Disease of supra-aortic (carotid/vertebrobasilar),
• A study to investigate the long-term safety, tolerability and efficacy of balinatunfib in participants with Crohn’s disease or ulcerative co … Recruiting
  2025-522511-42-00 4 2026-05-19 Crohn's disease
• ACP-204 in Adults With Lewy Body Dementia Psychosis (LBDP) Recruiting
  2025-521711-39-00 5 2026-05-17 Lewy body Dementia psychosis (LBDP)
• A Global Study Testing the New Drug Olverembatinib combined with chemotherapy for Patients with Newly Diagnosed Philadelphia Chromosome-Pos … Recruiting
  2024-511496-14-00 5 2026-05-14 Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic L

Showing 49–72 of 848 trials